Skip to main content
Log in

24S-Hydroxycholesterol and Cerebellar Degeneration: Insights from SCA2

  • Letter to the Editor
  • Published:
The Cerebellum Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Leoni V, Caccia C. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. Biochimie. 2013;95(3):595–612.

    Article  CAS  PubMed  Google Scholar 

  2. Leoni V, Caccia C. The impairment of cholesterol metabolism in Huntington disease. Biochim Biophys Acta. 2015;1851(8):1095–105.

    Article  CAS  PubMed  Google Scholar 

  3. Pikuleva IA, Cartier N. Cholesterol hydroxylating cytochrome P450 46A1: from mechanisms of action to clinical applications. Front Aging Neurosci. 2021;8(13): 696778.

    Article  Google Scholar 

  4. Björkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med. 2006;260(6):493–508.

    Article  PubMed  Google Scholar 

  5. Gamba P, Giannelli S, Staurenghi E, Testa G, Sottero B, Biasi F, Poli G, Leonarduzzi G. The controversial role of 24-S-hydroxycholesterol in Alzheimer’s disease. Antioxidants (Basel, Switzerland). 2021;10(5):740.

    CAS  PubMed  Google Scholar 

  6. Marcello A, Civra A, Milan Bonotto R, Nascimento Alves L, Rajasekharan S, Giacobone C, Caccia C, Cavalli R, Adami M, Brambilla P, Lembo D, Poli G, Leoni V. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients. Redox Biol. 2020;36: 101682.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. van de Kraats C, Killestein J, Popescu V, Rijkers E, Vrenken H, Lütjohann D, Barkhof F, Polman CH, Teunissen CE. Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis. Mult Scler. 2014;20(4):412–7.

    Article  PubMed  Google Scholar 

  8. Huang X, Sterling NW, Du G, Sun D, Stetter C, Kong L, Zhu Y, Neighbors J, Lewis MM, Chen H, Hohl RJ, Mailman RB. Brain cholesterol metabolism and Parkinson’s disease. Mov Disord. 2019;34(3):386–95.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Nóbrega C, Mendonça L, Marcelo A, Lamazière A, Tomé S, Despres G, Matos CA, Mechmet F, Langui D, den Dunnen W, de Almeida LP, Cartier N, Alves S. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia. Acta Neuropathol. 2019;138(5):837–58.

    Article  PubMed  Google Scholar 

  10. Meierhofer D, Halbach M, Şen NE, Gispert S, Auburger G. Ataxin-2 (Atxn2)-knock-out mice show branched chain amino acids and fatty acids pathway alterations. Mol Cell Proteomics. 2016;15(5):1728–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Schmitz-Hübsch T, Tezenas du Montcel S, Baliko L, Boesch S, Bonato S, Fancellu R, Giunti P, Globas C, Kang JS, Kremer B, Mariotti C, Melegh B, Rakowicz M, Rola R, Romano S, Schöls L, Szymanski S, van de Warrenburg BP, Zdzienicka E, Dürr A, Klockgether T. Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients. Mov Disord. 2006;21(5):699–704.

    Article  PubMed  Google Scholar 

  12. Schmitz-Hübsch T, Fimmers R, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, Mariotti C, Linnemann C, Schöls L, Timmann D, Filla A, Salvatore E, Infante J, Giunti P, Labrum R, Kremer B, van de Warrenburg BP, Baliko L, Melegh B, Depondt C, Schulz J, du Montcel ST, Klockgether T. Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology. 2010;74(8):678–84.

    Article  PubMed  Google Scholar 

  13. Jacobi H, Rakowicz M, Rola R, Fancellu R, Mariotti C, Charles P, Dürr A, Küper M, Timmann D, Linnemann C, Schöls L, Kaut O, Schaub C, Filla A, Baliko L, Melegh B, Kang JS, Giunti P, van de Warrenburg BP, Fimmers R, Klockgether T. Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument. Cerebellum. 2013;12(3):418–28.

    Article  CAS  PubMed  Google Scholar 

  14. Björkhem I, Cedazo-Minguez A, Leoni V, Meaney S. Oxysterols and neurodegenerative diseases. Mol Aspects Med. 2009;30(3):171–9.

    Article  PubMed  Google Scholar 

  15. Bretillon L, Sidén A, Wahlund LO, Lütjohann D, Minthon L, Crisby M, Hillert J, Groth CG, Diczfalusy U, Björkhem I. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett. 2000;293(2):87–90.

    Article  CAS  PubMed  Google Scholar 

  16. Scherzed W, Brunt ER, Heinsen H, de Vos RA, Seidel K, Bürk K, Schöls L, Auburger G, Del Turco D, Deller T, Korf HW, den Dunnen WF, Rüb U. Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3). Cerebellum. 2012;11(3):749–60.

    Article  CAS  PubMed  Google Scholar 

  17. Heck D, Sultan F. Cerebellar structure and function: making sense of parallel fibers. Hum Mov Sci. 2002;21(3):411–21.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the patients and their families for their willingness during the study. Thanks also go to Professor Maria Teresa Dotti and Professor Marina Del Puppo for their contribution in planning the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Mignarri.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Locci, S., Nidiaci, V., De Stefano, N. et al. 24S-Hydroxycholesterol and Cerebellar Degeneration: Insights from SCA2. Cerebellum 22, 1020–1022 (2023). https://doi.org/10.1007/s12311-022-01448-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12311-022-01448-7

Navigation